Telbivudine - Investigational Drug for Chronic Hepatitis B Infection

Print

Estimates from the World Health Organisation (WHO) suggest there are around 350 million people chronically infected with hepatitis B virus
 
«Back | Next»

Return to Profile




Home
New On This Site
Products & Services
Company A-Z
Industry Projects
White Papers
Jobs & Careers
Press Releases
Events & Exhibitions
Newsletter
Advertise With Us
About Us
Client Area

For every phase of your drug development